Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 15/20 | 0.55 |
| ▸ | CA1 | P00915 | 15/20 | 0.55 |
| ▸ | CA2 | P00918 | 15/20 | 0.55 |
| ▸ | CA4 | P22748 | 8/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.49 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.49 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6798502 | 0.85 | CA12 (0.55) | CA12CA1CA2CA4L3MBTL1 | |
| SCHEMBL6540099 | 0.83 | HTR6 (0.55) | CA12CA1CA2CA4L3MBTL1 | |
| SCHEMBL6541013 | 0.80 | CA12 (0.50) | CA12CA1CA2CA4LIMK1 | |
| SCHEMBL6540370 | 0.79 | ESR1 (0.51) | CA12CA1CA2CA4LIMK1 | |
| SCHEMBL6540868 | 0.79 | LPAR1 (0.55) | CA12CA1CA2CA4 | |
| SCHEMBL14583445 | 0.79 | HDAC3 (0.56) | CA12CA1CA2CA4 | |
| SCHEMBL7228409 | 0.78 | MEN1 (0.61) | CA12CA1CA2CA4L3MBTL1 | |
| SCHEMBL28262453 | 0.77 | CA1 (0.53) | CA12CA1CA2CA4 | |
| SCHEMBL6539996 | 0.76 | HTR6 (0.51) | CA12CA1CA2CA4L3MBTL1 | |
| SCHEMBL6540096 | 0.76 | LPAR1 (0.54) | CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | CA12 4283/4885CA1 4181/4885CA2 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.